Article
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Aug 2015
Serrano César, Wang Yuexiang, Mariño-Enríquez Adrián, Lee Jen-Chieh, Ravegnini Gloria, Morgan Jeffrey A, Bertagnolli Monica M, Beadling Carol, Demetri George D, Corless Christopher L, Heinrich Michael C, Fletcher Jonathan A
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.